2Sechi LA, De Marchi S. Relationship of Lp(a) to variables of coagulation in hypertensive subjects. J Invest Med, 2001, 49 (1) : 12-22.
3Scann AM, Nakajima K, Edelstein C. Apolipoprotein (a):structure and biology. Front Biosci, 2001, 6:D546-554.
4Zhao SP, Xu DY. Oxidized Lp (a) enhanced the expression of P-semection in cultured human umbilical cells. Thromb Res, 2000, 100 (6) : 501-510.
5Woo J, Lan E, Lam CW, Kay R, Teoh R, Wong HY, et al. Hypertension, lipoprotein(a), and apolipoproteinA-I as risk factors for storke in the Chinese.Stroke, 1991, 22 (10): 1 329-330.
6Levine DM, Sloan B J, Donner JE, et al. Automated measurement of Lp(a) by immunoturbidimetric analysis. Int J Clin Lab Res, 1992,22:173-178.
7Marcovina SM, Koschinsky ML. Lipoprotein ( a ) : Structure,measurement, and clinical significance, handbook of lipoprotein testing. 2nd Edition, AACC Press, 2000. 345-386.
8Marcovina SM, Albers JJ, Gabel B, et al. Effect of the number of apolipoprotein ( a ) kringle 4 domains on immunochemical measurements of lipopretein (a). Clin Chem, 1995, 41:246-255.
9Tate JR, Berg K, Couderc R, et al. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipopretein (a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein(a). Clin Chem Lab Med, 1999, 37:949-958.
10Seman LJ, Jenner JL, McNamara JR, et al. Quantification of lipoprotein (a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin Chem, 1994, 40:400-403.
